NeuroMotor Pen, Tool for Early Disease Diagnosis, Soon Widely Available

NeuroMotor Pen, Tool for Early Disease Diagnosis, Soon Widely Available
Manus Neurodynamica, a medical technology company, has raised £750,000 in a financing round to support the rollout of NeuroMotor Pen, a digital pen with a patented sensor technology to help diagnose at early stages movement disorders like Parkinson’s disease. The funding, worth about $950,000, will also be used to develop new technologies with clinical applications. The NeuroMotor Pen combines sensor technologies linked ... read more
Source: Parkinson’s News TodayPublished on 2020-06-09By Patricia Inacio, PhD